Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Ackermann currently holds 1,208,273 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Ackermann has been a net buyer of TARS stock. They have purchased $1.4M and sold $752.4K worth of shares.
Michael Ackermann's most recent insider trade was on Jun 15, 2022, when they sold 4,257 shares at $0.00 per share.
Michael Ackermann serves as Executive at Tarsus Pharmaceuticals, Inc. (TARS). They have executed 23 insider transactions totaling $2.1M over their tenure at the company.
Michael Ackermann holds the position of Executive at Tarsus Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Michael Ackermann has shown a buying trading pattern, with $1.4M in total purchases and $752.4K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael Ackermann was on May 5, 2022, when they purchased $1.4M worth of TARS shares. This transaction involved 100,000 shares at $13.50 per share.
Michael Ackermann currently owns 1,208,273 shares of Tarsus Pharmaceuticals, Inc. (TARS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Ackermann's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Ackermann has 23 Form 4 filings on record as an insider at Tarsus Pharmaceuticals, Inc..
Set alerts for Michael Ackermann and 40,000+ other insiders.